$4.7MSeries A, 26 May 2026
Funds final phase of a 1,000-patient pivotal trial, TGA and FDA submissions and manufacturing
- Amount
- $4.7M
- Stage
- Series A
- Announced
- 26 May 2026
- Lead
- Scale Investors
- Other investors
- Clare Ventures, University of Sydney
- Use of funds
- Funds final phase of a 1,000-patient pivotal trial, TGA and FDA submissions and manufacturing
- Checked
- Amount and date checked against the press source
- Source
- Birth monitoring startup Oli raises $6.5M Series A3 startupdaily.net